Volitionrx (VNRX) Enterprise Value (QoQ) (2020 - 2025)
Volitionrx (VNRX) Enterprise Value (QoQ) (2020 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.81 Bn | 175.52 Bn | 6.27 Bn |
| 2 | Stryker | 128.98 Bn | 126.10 Bn | 3.81 Bn |
| 3 | Medtronic | 108.67 Bn | 99.45 Bn | 6.41 Bn |
| 4 | Boston Scientific | 68.36 Bn | 66.91 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 47.70 Bn | 44.03 Bn | 1.29 Bn |
| 6 | Dexcom | 28.67 Bn | 27.55 Bn | 750.30 Mn |
| 7 | GE HealthCare Technologies | 28.55 Bn | 26.27 Bn | 1.98 Bn |
| 8 | Smith & Nephew | 26.97 Bn | 26.40 Bn | - |
| 9 | Koninklijke Philips | 25.45 Bn | 22.33 Bn | 2.07 Bn |
| 10 | Volitionrx | 92,593.09 | -1.02 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -62.73% |
| Sep 30, 2025 | 57.22% |
| Jun 30, 2025 | 8.16% |
| Mar 31, 2025 | 13.69% |
| Dec 31, 2024 | 31.84% |
| Sep 30, 2024 | 7.59% |
| Jun 30, 2024 | 44.57% |
| Mar 31, 2024 | 40.91% |
| Dec 31, 2023 | -86.27% |
| Sep 30, 2023 | 43.24% |
| Jun 30, 2023 | -92.08% |
| Mar 31, 2023 | 6.68% |
| Dec 31, 2022 | -596.28% |
| Sep 30, 2022 | 90.40% |
| Jun 30, 2022 | 27.99% |
| Mar 31, 2022 | -14.08% |
| Dec 31, 2021 | 9.16% |
| Sep 30, 2021 | 17.95% |
| Jun 30, 2021 | 15.57% |
| Mar 31, 2021 | -70.03% |